Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Mast Therapeutics Company Profile (NASDAQ:MSTX)

Consensus Ratings for Mast Therapeutics (NASDAQ:MSTX) (?)
Ratings Breakdown: 3 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $3.00 (361.54% upside)

Analysts' Ratings History for Mast Therapeutics (NASDAQ:MSTX)
Show:
DateFirmActionRatingPrice TargetDetailsShare
10/3/2013Canaccord GenuityInitiated CoverageReduce -> Buy$3.00ViewTweet This Rating  Share This Rating on StockTwits
10/3/2013Cantor FitzgeraldInitiated CoverageBuyViewTweet This Rating  Share This Rating on StockTwits
6/25/2013Piper JaffrayInitiated CoverageOverweightViewTweet This Rating  Share This Rating on StockTwits
4/2/2013JMP SecuritiesInitiated CoverageOutperform$2.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 4/23/2012 forward)